2/27 Safety
et al., Clinical Microbiology and Infection, doi:10.1016/j.cmi.2021.02.013 (Peer Reviewed)
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
Comparison of bradycardia in COVID-19 patients treated with remdesivir compared to those treated with HCQ, lopinavir/ritonavir, tocilizumab or glucocorticoids, finding increased risk of bradycardia with remdesivir.
Touafchia et al., 2/27/2021, peer-reviewed, 6 authors.
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.